ICI 215,001 hydrochloride is a β-adrenergic receptor antagonist with minimal intrinsic agonist activity, selectively blocking β1 and β2 subtypes. This compound is utilized in cardiovascular and pulmonary research to investigate adrenergic signaling pathways in both in vitro receptor binding assays and in vivo physiological studies.